Anti-Cisplatin modified DNA [CP9/19] | Ximbio 151464 product information

product summary

company name :

Ximbio

product type :

antibody

product name :

Anti-Cisplatin modified DNA [CP9/19]

catalog :

151464

clonality :

monoclonal

host :

rat

conjugate :

nonconjugated

clone name :

CP9/19

reactivity :

human

application :

ELISA, immunohistochemistry, immunoprecipitation, FACS

more info or order :

Ximbio product webpage

product information

Name :

Anti-Cisplatin modified DNA [CP9/19]

Catalogue Number :

151464

Applications :

ELISA FACS IHC IP DB

Antigen/Gene or Protein Targets :

Cisplatin modified native DNA

Relevance :

This antibody enables the quantification of cisplatin-induced adducts on DNA. This antibody has also been recently used for isolation of DNA fragments carrying adducts to enhance the sensitivity of subsequent PCR-based analyses and is central to ongoing studies of variation in the nature of cisplatin adducts formed in different cell lines. Antibody CP9/19 recognises only the intra-strand cross-links formed by cisplatin between adjacent purines.

Host :

Rat

Immunogen :

Cisplatin modified native DNA

Subclass :

IgG2a

Positive Control :

RNA/DNA

Myeloma Used :

Y3.AG.1.2.3

Recommended Growing Conditions :

DMEM + 10%FCS + Glu + Pen/Strep

Research Area :

DNA Damage and Repair, Epigenetics & Nuclear Signalling

Notes :

Alternative Name: ICR4

more info or order :

Ximbio product webpage